Team

Leadership Team

CEO  –  Mr Nathan Nagel

NATHAN NAGEL

Nathan is a medical and life science executive with 26 years experience, of which 15 is at executive board level. Nathan has worked in global medical education for around 12 years and has deep exprinace in oncology and robotic surgery. His current positions include CCO at MEMP, Chief Executive Officer of GRASP and owner of the Fratrem Group Ltd. His past experiences include Faculty at Barts X Medicine digital health program, CEO Gamlen Tableting Ltd – Global pharmaceutical compaction analysis equipment company, Managing Director Sanyal Bio LLC – Global contract research organization for metabolic disease, CEO Neuro-Bio Ltd – Oxford University Neuroscience biotechnology spin-out, CEO Oncology Pharma Ltd – International oncology pharmaceutical market intelligence company, Managing partner LifeScience Ventures Ltd – Healthcare Venture Capital Advisory, Senior Sales and Marketing – Bayer Diagnostics and Sales and marketing – Takeda Pharmaceuticals. He has lived and worked in multiple countries and enjoys working with a wide variety of people. Nathan has over 10 years experience as an international speaker & chairman and has featured on global TV channels like CNBC. He has also lectured on entrepreneurship at prestigious Universities such as Cambridge, Oxford, and Warwick.

CHIEF REGENERATIVE MEDICINE OFFICER – Asawari (Asa) Bapat (MD(DPB), PGDHHM, CABP(H)) 

DR ASAWARI BAPAT

Dr. Asawari (Asa) is a Medical Doctor with specialization in Clinical pathology, (Transfusion, Transplants, Lab Medicine and Immunology). She has 20+ years of Leadership experience as Medical Director, PI & Vice-President (USA, UAE, India & Australia), managing & supervising, Complex Diagnostic Labs, Facilities for Regenerative Medicine, Gene & Cell Therapy Companies, Designing successful Clinical Trials towards success. She has been piloting & managing international teams for complex technology transfers including evaluations, regulatory guidelines & risk analysis. Asa has built strong relationships & has optimized successful collaborations, business associations efficiently through her network. Currently she is a Consultant, Advisor & Counsel for many Biotechs, Pharmaceutical & Regenerative Medicine Facilities & Companies Globally. Validated global expert for:-Gene & Cell Therapies, Biotherapies. – Cord Blood Banks, Tissue Banks. -Clinical Trials in Regenerative Medicine Therapies & Devices, -International Quality Management Systems, -Optimization of Clinical services including Marketing, Logistics & on ground support. -Gap Audits- Internal, External, Supplier Evaluations, -Accreditations, Certifications (AABB, AATB, FACT, JCI, CAP, ISO, US FDA, DCGI, MOHAP and global regulations).

CHIEF ONCOLOGY OFFICER  –  Dr. Nick Plowman, MD, FRCP, FRCR

Dr Nick PlowmanDr Nick Plowman is a consultant clinical oncologist and the Head of Clinical Oncology (Cancer Medicine and Radiation Therapy) at St Bartholomew’s Hospital, London and Hospital for Sick Children in London for thirty years. Dr Plowman is an authority on the optimal management of cancer and leads one of the country’s foremost teams tackling all cancers. He was trained and qualified at Cambridge University, and works globally with experience in the UK, EU, USA, and the Middle East. He is one of the country’s most experienced cancer physicians and, with his clinical team, has introduced new medical therapies, which are now standard practice. During his career, he has introduced aromatase inhibitors into breast cancer treatment (the most important innovation in breast cancer in the last forty years) and introduced adrenosuppresive glucocorticoid therapy into advanced prostate cancer (now best standard practice worldwide). He has also introduced radiation techniques that have been initially pioneering and later best standard practice. In his career he has changed best standard management in breast cancer, prostate cancer, ano-rectal cancer (aromatase inhibitors, adrenosuppression, and chemoradiotherapy respectively). His current interests include radiation therapy developments (new focal and proton beam) and modern genomics.

CHIEF OF ROBOTIC SURGERY – Dr Sami Alasari, MBBS, ACS, FISUCRS

Dr. Sami is a consultant General surgeon, Robotic and Laparoscopic Bariatric surgeon, Oncology Colorectal surgery and Pelvic Floor Disorders, Almouwasat Hospital, Alkhobar Saudi Arabia. Bachelor degree in medicine and surgery MBBS, from King Faisal University, Dammam, Saudi Arabi. Saudi Board in General Surgery at King Faisal Specialist Hospital and research center, Riyadh, Saudi Arabia. Arab Board in General Surgery, King Faisal Specialist Hospital and research center, Riyadh, Saudi Arabia + Damascus, Syria. Fellow of the American College of Surgeons (ACS). Clinical and research laparoscopic and robotic oncology colorectal surgery and pelvic floor disorders fellowship at Yonsie University Health System. Severance Hospital, Seoul, South Korea. Clinical and research pelvic floor and incontinence management fellowship at Nantes University Hospital, Nantes, France. Fellow of International Society of University Colon and Rectal Surgeons (FISUCRS), Pennsylvania, USA. Clinical fellowship in bariatric surgery diniques Universitaires de Bruxelles, ULB – Free University of Brussels

 

CHIEF OF PLASTIC SURGERY – Dr. Martain Pierre Jean Loonen, M.D., Ph.D., FCC(Plast)

Dr. Martain Loonen is a highly accomplished Board-Certified Consultant Plastic Surgeon with over 14 years of experience in plastic, reconstructive, cosmetic, and hand surgery. He is also an expert in post-bariatric surgery, burn management, and medical management. His additional expertise in 3D surgical simulation and planning, as well as his involvement in developing new cartilage regenerative surgical treatments sets him apart from his peers. His research and articles have been published in prestigious international journals, such as Plastic and Reconstruction Surgery, and he is an invited peer reviewer for various international journals, including the American Journal of Plastic and Reconstructive Surgery, British Journal of Medicine and Medical Research, and the International Blood Research and Reviews. Dr. Martain has published a new breast reduction surgical technique, and his work has been cited over 400 times in the international scientific literature. He is an editorial board member for 16 international surgical and non-surgical journals, a testament to his expertise and knowledge in the field of plastic surgery.